Community-acquired pneumonia in Europe: Causative pathogens and resistance patterns

European Respiratory Journal, Supplement

Volumn 20, Issue 36, 2002, Pages

  Woodhead, M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Aetiology; Bacterial resistance; Community acquired pneumonia; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; MACROLIDE; OFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; CONFERENCE PAPER; COUGHING; DISEASE SEVERITY; DYSPNEA; GEOGRAPHY; HUMAN; INFLAMMATION; LUNG; PRIORITY JOURNAL; SPUTUM; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; ADULT; BACTERIAL PNEUMONIA; COMMUNICABLE DISEASE; DRUG EFFECT; EUROPE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; PATHOGENICITY; REVIEW;

ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EUROPE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; PNEUMONIA, BACTERIAL;

EID: 0036062153     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (86)

1. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: A prospective multicentre study
2. Epidemiology of community-acquired pneumonia in adults: A population-based study
3. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland
4. Prospective study of the aetiology and outcome of pneumonia in the community
5. Community-acquired pneumonia. A prospective outpatient study
6. Of a peripneumony, or inflammation of the lungs
7. Beitrage zur kenntniss der pathogenen schistomyceten
8. Note sur la maladie nouvelle provoquee par la salive d'un enfant mort de la rage
9. A fatal form of septicaemia in the rabbit, produced by subcutaneous injection of human saliva. An experimental research
10. Ueber die schizomyceten bei der acuten fibrosen pneumonie
11. Die mikrokokken der pneumonie
12. Ueber die aetiologie der acuten lungen und rippenfellentzundungen
13. An acute infection of the respiratory tract with atypical pneumonia
14. Mycoplasma pneumoniae: Proposed nomenclature for atypical pneumonia organism (Eaton Agent)
15. Beitrag zur frage des pneumotyphus (eine hausepidemie in Uster (Schweiz) betreffend)
16. A virus obtained from influenza patients
17. Experimental studies on virus of "Q" fever
18. Legionnaires' disease: Isolation of a bacterium and demonstration of its role in other respiratory disease
19. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
20. The occurrence of sulfonamide-resistant pneumococci in clinical practice
21. Tetracycline-resistant pneumococci
22. Pneumococcus resistant to erythromycin and lincomycin
23. A resistant pneumococcus
24. Aetiology and outcome of severe community-acquired pneumonia
25. The outcome of community-acquired pneumonia treated on the intensive care unit
26. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalised patients in Berlin
27. BTS Guidelines for the management of community-acquired pneumonia in Adults
28. Epidemiological features of Coxiella burnetii infection in England and Wales: 1984-1994
29. Prognostic factors of severe Legionella pneumonia requiring admission to ICU
30. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit
31. Severe community-acquired pneumonia. Etiology, prognosis and treatment
32. Severe community-acquired pneumonia. Epidemiology and prognostic factors
33. A three year study of severe community-acquired pneumonia with emphasis on outcome
34. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission
35. A five year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit
36. Severe community-acquired pneumonia. Etiology, epidemiology and prognosis factors
37. A new diagnostic approach to the patient with severe pneumonia
38. Severe community-acquired pneumonia: Factors influencing need of intensive care treatment and prognosis
39. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization
40. Community-acquired pneumonia: Is there difference in etiology between hospitalized and outpatients
41. Etiology of community-acquired pneumonia in patients requiring hospitalization
42. Etiology of community-acquired pneumonia in outpatients
43. Aetiology of community-acquired pneumonia in Valencia, Spain: A multicentre prospective study
44. Pneumonia - A clinical or radiographic diagnosis?
45. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland
46. Hospital study of adult community-acquired pneumonia
47. Community-acquired pneumonia in adults in British hospitals in 1982-1983: A survey of aetiology, mortality, prognostic factors and outcome
48. Causes of pneumonia presenting to a district general hospital
49. Adult community-acquired pneumonia in central London
50. Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines
51. Etiologic study of patients with community-acquired pneumonia
52. Legionella pneumophila. A cause of severe community-acquired pneumonia
53. Prospective study of epidemiology and prognostic factors in community-acquired pneumonia
54. Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain
55. Aetiology of community-acquired pneumonia in hospital treated patients
56. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens
57. Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture or serology
58. Emerging pathogens of community-acquired pneumonia: A twoyear prospective study
59. Aetiology of community-acquired pneumonia: A prospective study among adults requiring admission to hospital
60. Community-acquired pneumonia. Importance of initial non-invasive bacteriologic and radiographic investigations
61. Prevalence of legionellosis among adults: A study of community-acquired pneumonia in France
62. Legionella: An infrequent cause of adult community-acquired pneumonia in Dublin
63. Incidence and clinical features of community-acquired legionellosis in hospitalized patients
64. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features
65. Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicentre study
66. The rise and fall of Legionnaires' disease in Nottingham
67. Q fever in the Basque Country: 1981-1984
68. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparison between chlamydial and pneumococcal pneumonia
69. Local surveillance of antimicrobial resistance
70. Microbial aetiology of community-acquired pneumonia in hospitalised patients
71. Comparative study of the clinical presentation of legionella pneumonia and other community-acquired pneumonias
72. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
73. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
74. Pneumococcal bacteraemia with especial reference to bacteraemic pneumococcal pneumonia
75. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence
76. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia
77. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae
78. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci
79. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
80. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America
81. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: A randomized study of amoxicillinclavulanate and ceftriaxone
82. Pneumococcal macrolide resistancemyth or reality?
83. Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy
84. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada